Get started
Author

Michihiro Maemoto

Institution: Kyowa Kirin (Japan)
ORCID: 0000-0002-0891-6692
Observed ORCID: 0000-0002-0891-6692
OpenAlex ID: A5006177475
The design, synthesis and evaluation of 2-aminobenzoxazole analogues as potent and orally efficacious ChemR23 inhibitors
2020 · Takamichi Imaizumi, Shigeki Otsubo, et al. · Bioorganic & Medicinal Chemistry · 19
Discovery and mechanistic study of thiazole-4-acylsulfonamide derivatives as potent and orally active ChemR23 inhibitors with a long-acting effect in cynomolgus monkeys
2022 · Takamichi Imaizumi, Shigeki Otsubo, et al. · Bioorganic & Medicinal Chemistry · 7
Stereoselective Synthesis of 2,6-syn-Dimethyl-tetrahydropyran Derivatives, Important Segments of Marine Polycyclic Ethers, by Unique Insertion of the Methyl Group
2009 · Michihiro Maemoto, Atsushi Kimishima, et al. · Organic Letters · 7
Screening for DAX1 / EWS‐FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma
2023 · Miwa Watanabe, Hiromichi Kosaka, et al. · Cancer Medicine · 6
PDF
Discovery of Gut-Restricted Small-Molecule Inhibitors of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia
2022 · Michihiro Maemoto, Yuuki Hirata, et al. · Journal of Medicinal Chemistry · 5
Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b)
2022 · Michihiro Maemoto, Yuuki Hirata, et al. · Bioorganic & Medicinal Chemistry · 3
PDF
Corrigendum to “Discovery and mechanistic study of thiazole-4-acylsulfonamide derivatives as potent and orally active ChemR23 inhibitors with a long-acting effect in cynomolgus monkeys” [Bioorg. Med. Chem. 56 (2022) 116587]
2022 · Takamichi Imaizumi, Shigeki Otsubo, et al. · Bioorganic & Medicinal Chemistry
Abstract A155: Small molecule metabolic inhibitors, compound A and the derivatives specifically inhibit the cell growth of Ewing's sarcoma cells harbor EWS-FLI1 in vitro and in vivo
2015 · Hiromichi Kosaka, Yasuo Watanabe, et al. · Molecular Cancer Therapeutics
Works count: 8
Citation count: 47
H-index: 5
I10-index: 1
Year
Topic
Type